The National Institute for Health and Clinical Excellence has provisionally rejected the NHS use of abiraterone, a drug that can extend the life expectancy of men with advanced prostate cancer by 4 months on average. They claim the costs involved are too expensive at £3,500 a month. Steven
RPS Chief Science Advisor Professor Jayne Lawrence talked to the BBC about current Astra Zeneca plans to cut 7,300 jobs.
Responding to research in the British Medicial Journal that Proton Pump Inhibitors increase the risk of hip fracture in post menopausal women Dan Greer, Royal Pharmaceutical Society spokesperson on gastroenterology medicines said
Editors of three leading healthcare publications have heavily criticised the government’s proposed NHS reforms, calling for a public debate on its future to “salvage some good” from the plans.
In an editorial published simultaneously by the BMJ, Health Service Journal and Nursing Times, the editors of the three publications have said the NHS “is far too important to be left at
Following the successful launch of the inaugural NPA Health Education Foundation bursary in 2011, applications are now open for the 2012 bursary.
The £10,000 bursary aims to support pharmacists who have an interest in developing their skills to undertake research relating to community pharmacy practice.
More information is available from The Secretary to the Trustees, Janet Misson, on [email protected] or 01727 858687.